603811 诚意药业
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)11.05516.36814.28815.58018.363
总资产报酬率 ROA (%)8.34611.0859.02010.62513.505
投入资产回报率 ROIC (%)9.58912.65110.17511.97015.856

边际利润分析
销售毛利率 (%)70.95969.53464.17768.42470.875
营业利润率 (%)27.53930.96525.89425.10528.609
息税前利润/营业总收入 (%)28.06331.67026.88725.53428.274
净利润/营业总收入 (%)24.22128.10724.12824.60924.674

收益指标分析
经营活动净收益/利润总额(%)84.17753.53968.55173.78380.894
价值变动净收益/利润总额(%)17.15019.82233.40026.32720.867
营业外收支净额/利润总额(%)-0.333-1.4080.088-0.359-0.524

偿债能力分析
流动比率 (X)1.4411.3501.5101.6931.166
速动比率 (X)0.9850.8981.1691.2630.692
资产负债率 (%)21.44226.80636.78036.54024.470
带息债务/全部投入资本 (%)7.44614.78825.75427.34213.030
股东权益/带息债务 (%)1,216.234561.756279.585257.363656.046
股东权益/负债合计 (%)364.483271.972171.272173.186304.777
利息保障倍数 (X)45.62327.91927.71849.226-151.908

营运能力分析
应收账款周转天数 (天)16.19027.63636.46837.16636.905
存货周转天数 (天)200.235205.624170.442198.476210.404